RWMHX
Price
$67.11
Change
+$0.49 (+0.74%)
Updated
Jul 2 closing price
Net Assets
218.08B
USPCX
Price
$33.59
Change
+$0.42 (+1.27%)
Updated
Jul 2 closing price
Net Assets
87.7M
Interact to see
Advertisement

RWMHX vs USPCX

RWMHX vs USPCX Comparison Chart in %
View a ticker or compare two or three
VS
RWMHX vs. USPCX commentary
Jul 04, 2026

To compare these two companies we present long-term analysis, their fundamental ratings and make comparative short-term technical analysis which are presented below. The conclusion is RWMHX is a Buy and USPCX is a Buy.

Interact to see
Advertisement
FUNDAMENTALS
Fundamentals
RWMHX has more cash in the bank: 218B vs. USPCX (87.7M). RWMHX pays higher dividends than USPCX: RWMHX (1.35) vs USPCX (0.00). RWMHX was incepted earlier than USPCX: RWMHX (11 years) vs USPCX (15 years). USPCX (2.44) is less costly to investors than RWMHX (0.41). RWMHX is a more actively managed with annual turnover of: 29.00 vs. USPCX (12.93). RWMHX has a lower initial minimum investment than USPCX: RWMHX (250) vs USPCX (2500). USPCX annual gain was more profitable for investors over the last year : 11.89 vs. RWMHX (6.56). USPCX return over 5 years is better than : 38.74 vs. RWMHX (27.34).
RWMHXUSPCXRWMHX / USPCX
Total Expense Ratio0.412.1519%
Annual Report Gross Expense Ratio0.412.4417%
Fund Existence11 years15 years-
Gain YTD3.9255.79568%
Front LoadN/AN/A-
Min. Initial Investment250250010%
Min. Initial Investment IRAN/AN/A-
Net Assets218B87.7M248,575%
Annual Yield % from dividends1.350.00-
Returns for 1 year6.5611.8955%
Returns for 3 years30.2127.72109%
Returns for 5 years27.3438.7471%
Returns for 10 years80.70145.7655%
View a ticker or compare two or three
Interact to see
Advertisement
Interesting Tickers
1D
1W
1M
1Q
6M
1Y
5Y
1 Day
MFs / NAMEPrice $Chg $Chg %
MADRX26.670.46
+1.76%
Madison Dividend Income R6
FHCCX41.080.70
+1.73%
Fidelity Advisor Health Care C
MYISX26.640.06
+0.23%
Victory Integrity Small/Mid-Cap Value Y
SSPIX111.210.01
+0.01%
SEI S&P 500 Index F (SIMT)
RRMGX88.04-0.29
-0.33%
T. Rowe Price Mid-Cap Growth R